Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Inflammation × Omeprazole × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Gastrointestinal 1 Breast 1

Conditions

Obesity 1 Inflammation 1 Breast Neoplasms 1

Interventions

semaglutide 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Topiramate 1 Tirzepatide 1 Tablets 1 Specimen Handling 1 Qsymia 1 Pregabalin 1 Phentermine 1 Omeprazole 1 Nutrition Assessment 1 Naltrexone 1 Liraglutide 1 Ketorolac 1 Glucagon-Like Peptide-1 Receptor 1 Exercise 1 Diethylpropion 1 Diet 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡